Peter Amersdorfer

1.9k total citations
15 papers, 1.5k citations indexed

About

Peter Amersdorfer is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Peter Amersdorfer has authored 15 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Neurology. Recurrent topics in Peter Amersdorfer's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Botulinum Toxin and Related Neurological Disorders (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Peter Amersdorfer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Botulinum Toxin and Related Neurological Disorders (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Peter Amersdorfer collaborates with scholars based in United States, Austria and Hungary. Peter Amersdorfer's co-authors include James D. Marks, Gábor Méhes, Sebastian Mannweiler, Theresa J. Smith, Robert E. Sheridan, Slave Trajanoski, David King, Jonathan Terrett, Cindy Wong and Ricarda Finnern and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Infection and Immunity.

In The Last Decade

Peter Amersdorfer

14 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Amersdorfer United States 12 821 797 367 300 287 15 1.5k
Marina Cardó‐Vila United States 25 1.0k 1.2× 431 0.5× 28 0.1× 113 0.4× 67 0.2× 31 1.7k
Fraser Conrad United States 16 362 0.4× 251 0.3× 276 0.8× 33 0.1× 209 0.7× 25 748
Dominique Piatier‐Tonneau France 20 429 0.5× 190 0.2× 52 0.1× 57 0.2× 141 0.5× 36 1.3k
James D. Marks United States 8 1.3k 1.6× 1.6k 1.9× 84 0.2× 23 0.1× 50 0.2× 10 1.9k
Abraham Scaria United States 22 1.7k 2.1× 186 0.2× 41 0.1× 67 0.2× 71 0.2× 54 2.4k
Colleen M. Cebulla United States 26 966 1.2× 284 0.4× 60 0.2× 330 1.1× 66 0.2× 89 2.4k
I Hellström United States 18 585 0.7× 656 0.8× 109 0.3× 68 0.2× 21 0.1× 37 1.4k
Randy Robinson United States 13 767 0.9× 773 1.0× 148 0.4× 58 0.2× 7 0.0× 31 1.5k
Arne Bakker Netherlands 23 542 0.7× 145 0.2× 66 0.2× 90 0.3× 53 0.2× 30 1.9k
R A Reisfeld United States 18 805 1.0× 629 0.8× 246 0.7× 20 0.1× 16 0.1× 28 1.3k

Countries citing papers authored by Peter Amersdorfer

Since Specialization
Citations

This map shows the geographic impact of Peter Amersdorfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Amersdorfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Amersdorfer more than expected).

Fields of papers citing papers by Peter Amersdorfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Amersdorfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Amersdorfer. The network helps show where Peter Amersdorfer may publish in the future.

Co-authorship network of co-authors of Peter Amersdorfer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Amersdorfer. A scholar is included among the top collaborators of Peter Amersdorfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Amersdorfer. Peter Amersdorfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Schlick, Bettina, Petra Massoner, Angelika Lueking, et al.. (2016). Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients. PLoS ONE. 11(2). e0147739–e0147739. 11 indexed citations
3.
Massoner, Petra, Angelika Lueking, Heike Goehler, et al.. (2011). Serum‐autoantibodies for discovery of prostate cancer specific biomarkers. The Prostate. 72(4). 427–436. 33 indexed citations
4.
Mannweiler, Sebastian, Peter Amersdorfer, Slave Trajanoski, et al.. (2008). Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis. Pathology & Oncology Research. 15(2). 167–172. 297 indexed citations
5.
Baden, Jonathan, Haiying Wang, Yashoda Rajpurohit, et al.. (2008). Development of a Multiplexed Urine Assay for Prostate Cancer Diagnosis. Clinical Chemistry. 54(5). 874–882. 51 indexed citations
6.
Lueking, Angelika, et al.. (2008). Determination and Validation of Off-Target Activities of Anti-CD44 Variant 6 Antibodies Using Protein Biochips and Tissue Microarrays. BioTechniques. 45(sup4). Pi–v. 15 indexed citations
7.
Amersdorfer, Peter & James D. Marks. (2003). Phage Libraries for Generation of Anti-Botulinum scFv Antibodies. Humana Press eBooks. 145. 219–240. 12 indexed citations
8.
Amersdorfer, Peter, Cindy Wong, Theresa J. Smith, et al.. (2002). Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries. Vaccine. 20(11-12). 1640–1648. 79 indexed citations
9.
Powers, David B., Peter Amersdorfer, Theresa J. Smith, et al.. (2002). Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proceedings of the National Academy of Sciences. 99(17). 11346–11350. 268 indexed citations
10.
Powers, David B., Peter Amersdorfer, Marie‐Alix Poul, et al.. (2001). Expression of single-chain Fv-Fc fusions in Pichia pastoris. Journal of Immunological Methods. 251(1-2). 123–135. 105 indexed citations
11.
Sheridan, Robert E., S.S. Deshpande, Peter Amersdorfer, James D. Marks, & Theresa J. Smith. (2001). Anomalous enhancement of botulinum toxin type A neurotoxicity in the presence of antitoxin. Toxicon. 39(5). 651–657. 11 indexed citations
12.
Lecerf, Jean‐Michel, Thomas L. Shirley, Quan Zhu, et al.. (2001). Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease. Proceedings of the National Academy of Sciences. 98(8). 4764–4769. 165 indexed citations
13.
Sheets, Michael, Peter Amersdorfer, Ricarda Finnern, et al.. (1998). Efficient construction of a large nonimmune phage antibody library: The production of high-affinity human single-chain antibodies to protein antigens. Proceedings of the National Academy of Sciences. 95(11). 6157–6162. 356 indexed citations
14.
Amersdorfer, Peter, Theresa J. Smith, Shripad B. Deshpande, et al.. (1997). Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries. Infection and Immunity. 65(9). 3743–3752. 86 indexed citations
15.
Amersdorfer, Peter, et al.. (1997). Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms. Infection and Immunity. 65(5). 1626–1630. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Cardó‐Vila Breakdown of academic impact, for papers by Fraser Conrad Breakdown of academic impact, for papers by Dominique Piatier‐Tonneau Breakdown of academic impact, for papers by James D. Marks Breakdown of academic impact, for papers by Abraham Scaria Breakdown of academic impact, for papers by Colleen M. Cebulla Breakdown of academic impact, for papers by I Hellström Breakdown of academic impact, for papers by Randy Robinson Breakdown of academic impact, for papers by Arne Bakker Breakdown of academic impact, for papers by R A Reisfeld
Rankless by CCL
2026